Home > Insider Trading > Filing (0001437749-17-003889)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1586049	Oxford Immunotec Global Plc	OXFD	In Vitro & In Vivo Diagnostic Substances (2835)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1592279	Peter Edwardson	C/O Oxford Immunotec Global Plc 94C Innovation Drive Abingdon, Oxfordshire X0 OX14 4RZ	Chief Operations Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2017-02-24	6,968	$0.00	54,194	No	4	A	Direct
Ordinary Shares	Disposition	2017-03-03	5,923	$14.92	48,271	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (Right to Buy)	Acquisiton	2017-02-24	31,650	$0.00	31,650	$13.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,650		2027-02-24	No	4	A	Direct

Footnotes

The price reported for the sales on March 3, 2017 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.86 to $15.00 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
Option granted under Issuer's 2013 Share Incentive Plan.
Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2018 through January 1, 2021.